📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits. (2020)

First Author: Faulkner V

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fmicb.2020.619427

PubMed Identifier: 33597931

Publication URI: http://europepmc.org/abstract/MED/33597931

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in microbiology

ISSN: 1664-302X